Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

LC10013

Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases/100 cores, replacing LC1002
Unstained: $215.00 Add to Cart
H&E (LC10013s*): $215.00 Add to Cart

Microarray Panel:Lung adenocarcinoma tissue microarray with adjacent normal lung tissue, containing 24 cases of lung adenocarcinoma plus 22 adjacent normal lung tissue and 4 normal lung tissue, duplicate cores per case
Cores:100
Cases:50
Layout:10 cols × 10 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
B Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
C Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
D Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
E Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
F Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
G Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
H Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
I Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
J Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun Marked point
Legend: Lun - Lung

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IV), - NAT, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 42 Lung Adenocarcinoma 2 IIIb T4N1M0 Malignant
A2 2 F 39 Lung Adenocarcinoma (tumoral necrosis) – I T2N0M0 Malignant
A3 3 M 50 Lung Adenocarcinoma 3 IIIa T3N0M0 Malignant
A4 4 M 75 Lung Adenocarcinoma 2 I T2N0M0 Malignant
A5 5 F 59 Lung Adenocarcinoma with necrosis 2 II T2N1M0 Malignant
A6 6 M 62 Lung Adenocarcinoma 2 IV T2N1M1 Malignant
A7 7 M 51 Lung Adenocarcinoma 2 II T2N1M0 Malignant
A8 8 M 49 Lung Adenocarcinoma 3 II T1N1M0 Malignant
A9 9 M 59 Lung Adenocarcinoma 2 II T2N1M0 Malignant
A10 10 M 65 Lung Adenocarcinoma 2 IIIa T3N2M0 Malignant
B1 11 F 54 Lung Adenocarcinoma 2 IIIa T3N1M0 Malignant
B2 12 M 61 Lung Adenocarcinoma with necrosis 2 II T2N1M0 Malignant
B3 13 F 59 Lung Adenocarcinoma with necrosis 2 I T2N0M0 Malignant
B4 14 F 65 Lung Adenocarcinoma (mucosa) – I T2N0M0 Malignant
B5 15 M 51 Lung Adenocarcinoma 2 I T1N0M0 Malignant
B6 16 F 37 Lung Adenocarcinoma 2 I T2N0M0 Malignant
B7 17 F 52 Lung Adenocarcinoma 2 II T2N1M0 Malignant
B8 18 F 52 Lung Adenocarcinoma 2 II T2N1M0 Malignant
B9 19 M 62 Lung Adenocarcinoma 2 I T2N0M0 Malignant
B10 20 F 49 Lung Adenocarcinoma 2 I T2N0M0 Malignant
C1 21 F 42 Lung Adenocarcinoma 2 I T2N0M0 Malignant
C2 22 M 55 Lung Adenocarcinoma 2 I T2N0M0 Malignant
C3 23 M 70 Lung Adenocarcinoma 2 I T2N0M0 Malignant
C4 24 M 52 Lung Adenocarcinoma 2 II T2N1M0 Malignant
C5 25 F 37 Lung Adenocarcinoma 2 I T2N0M0 Malignant
C6 26 F 63 Lung Adenocarcinoma 2 I T2N0M0 Malignant
C7 27 F 64 Lung Adenocarcinoma 2 I T2N0M0 Malignant
C8 28 M 70 Lung Adenocarcinoma (lung tissue) – I T2N0M0 Malignant
C9 29 M 40 Lung Adenocarcinoma 3 I T2N0M0 Malignant
C10 30 F 62 Lung Adenocarcinoma 2 I T2N0M0 Malignant
D1 31 M 64 Lung Adenocarcinoma 3 I T2N0M0 Malignant
D2 32 M 63 Lung Adenocarcinoma 3 I T2N0M0 Malignant
D3 33 M 58 Lung Adenocarcinoma 2 I T2N0M0 Malignant
D4 34 F 58 Lung Adenocarcinoma 3 I T2N0M0 Malignant
D5 35 F 32 Lung Adenocarcinoma 3 I T2N0M0 Malignant
D6 36 M 69 Lung Adenocarcinoma 3 I T2N0M0 Malignant
D7 37 F 68 Lung Adenocarcinoma 3 II T2N1M0 Malignant
D8 38 F 61 Lung Adenocarcinoma (carcinoma sparse) – I T2N0M0 Malignant
D9 39 M 62 Lung Adenocarcinoma 3 IIIa T3N0M0 Malignant
D10 40 F 72 Lung Adenocarcinoma 3 II T2N1M0 Malignant
E1 41 M 60 Lung Adenocarcinoma 3 I T2N0M0 Malignant
E2 42 M 49 Lung Adenocarcinoma 3 I T2N0M0 Malignant
E3 43 F 46 Lung Adenocarcinoma 3 I T1N0M0 Malignant
E4 44 M 65 Lung Adenocarcinoma 3 IIIa T3N0M0 Malignant
E5 45 F 62 Lung Adenocarcinoma (lung tissue) – I T2N0M0 Malignant
E6 46 F 36 Lung Adenocarcinoma (fibrous tissue and blood vessel) – IIIa T2N2M0 Malignant
E7 47 M 39 Lung Adenocarcinoma 3 I T2N0M0 Malignant
E8 48 F 58 Lung Adenocarcinoma – IIIa T3N0M0 Malignant
E9 49 F 42 Lung Cancer adjacent normal lung tissue – – – NAT
E10 50 F 39 Lung Cancer adjacent normal lung tissue – – – NAT
F1 51 M 50 Lung Cancer adjacent normal lung tissue (emphysema) – – – NAT
F2 52 M 75 Lung Cancer adjacent normal lung tissue – – – NAT
F3 53 F 59 Lung Cancer adjacent normal lung tissue – – – NAT
F4 54 M 62 Lung Cancer adjacent normal lung tissue – – – NAT
F5 55 M 51 Lung Cancer adjacent normal lung tissue – – – NAT
F6 56 M 49 Lung Cancer adjacent normal lung tissue – – – NAT
F7 57 M 59 Lung Cancer adjacent normal lung tissue – – – NAT
F8 58 M 65 Lung Cancer adjacent normal lung tissue (pulmonary collapse) – – – NAT
F9 59 F 54 Lung Cancer adjacent normal lung tissue (pulmonary collapse) – – – NAT
F10 60 M 61 Lung Cancer adjacent normal lung tissue – – – NAT
G1 61 F 59 Lung Cancer adjacent normal lung tissue – – – NAT
G2 62 F 65 Lung Cancer adjacent normal lung tissue – – – NAT
G3 63 M 51 Lung Cancer adjacent normal lung tissue – – – NAT
G4 64 F 37 Lung Cancer adjacent normal lung tissue – – – NAT
G5 65 F 52 Lung Cancer adjacent normal lung tissue – – – NAT
G6 66 F 52 Lung Cancer adjacent normal lung tissue – – – NAT
G7 67 M 62 Lung Cancer adjacent normal lung tissue – – – NAT
G8 68 F 49 Lung Cancer adjacent normal lung tissue – – – NAT
G9 69 F 42 Lung Cancer adjacent normal lung tissue – – – NAT
G10 70 M 55 Lung Cancer adjacent normal lung tissue – – – NAT
H1 71 M 70 Lung Cancer adjacent normal lung tissue – – – NAT
H2 72 M 52 Lung Cancer adjacent normal lung tissue – – – NAT
H3 73 F 37 Lung Cancer adjacent normal lung tissue – – – NAT
H4 74 F 63 Lung Cancer adjacent normal lung tissue – – – NAT
H5 75 F 64 Lung Cancer adjacent normal lung tissue (adenocarcinoma) – – – NAT
H6 76 M 70 Lung Cancer adjacent normal lung tissue – – – NAT
H7 77 M 40 Lung Cancer adjacent normal lung tissue – – – NAT
H8 78 F 62 Lung Cancer adjacent normal lung tissue – – – NAT
H9 79 M 64 Lung Cancer adjacent normal lung tissue – – – NAT
H10 80 M 63 Lung Cancer adjacent normal lung tissue – – – NAT
I1 81 M 58 Lung Cancer adjacent normal lung tissue – – – NAT
I2 82 F 58 Lung Cancer adjacent normal lung tissue – – – NAT
I3 83 F 32 Lung Cancer adjacent normal lung tissue – – – NAT
I4 84 M 69 Lung Cancer adjacent normal lung tissue – – – NAT
I5 85 F 68 Lung Cancer adjacent normal lung tissue – – – NAT
I6 86 F 61 Lung Cancer adjacent normal lung tissue – – – NAT
I7 87 M 62 Lung Cancer adjacent normal lung tissue – – – NAT
I8 88 F 72 Lung Cancer adjacent normal lung tissue – – – NAT
I9 89 M 60 Lung Cancer adjacent normal lung tissue – – – NAT
I10 90 M 49 Lung Cancer adjacent normal lung tissue – – – NAT
J1 91 F 46 Lung Cancer adjacent normal lung tissue – – – NAT
J2 92 M 65 Lung Cancer adjacent normal lung tissue – – – NAT
J3 93 F 62 Lung Cancer adjacent normal lung tissue – – – NAT
J4 94 F 36 Lung Cancer adjacent normal lung tissue – – – NAT
J5 95 M 39 Lung Cancer adjacent normal lung tissue – – – NAT
J6 96 F 58 Lung Cancer adjacent normal lung tissue – – – NAT
J7 97 M 24 Lung Normal lung tissue – – – Normal
J8 98 M 48 Lung Normal lung tissue – – – Normal
J9 99 F 15 Lung Normal lung tissue – – – Normal
J10 100 M 47 Lung Normal lung tissue – – – Normal
– – F 55 liver Hepatocellular liver cancer (tissue marker) 3 T3N0M0 Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal